Allaix Marco E, Giraudo Giuseppe, Mistrangelo Massimiliano, Arezzo Alberto, Morino Mario
Department of Surgical Sciences, University of Torino, Corso Dogliotti 14, 10126, Turin, Italy,
Surg Endosc. 2015 Apr;29(4):916-24. doi: 10.1007/s00464-014-3752-y. Epub 2014 Aug 9.
Laparoscopic resection (LR) and open resection (OR) for colon cancer have similar oncologic outcomes at 5-year follow-up. However, results from studies with longer follow-up are limited. This study aimed to compare 10-year oncologic outcomes of LR and OR for non-metastatic colon cancer.
A prospective non-randomized trial comparing patients undergoing LR or OR for non-metastatic colon cancer at a single institution was conducted. Statistical analyses were performed on an ''intention-to-treat'' basis and by actual treatment. Kaplan-Meier curves were compared to analyze overall survival (OS) and disease-free survival (DFS). A multivariate analysis was performed to identify predictors of poor survival.
The study included 304 colon cancer patients: 154 patients underwent LR and 150 underwent OR. Fifteen (9.7 %) had LR converted to OR. During a median follow-up period of 138 (range, 120-220) months, no significant differences were observed between LR and OR patients in 10-year OS and DFS rates: 87.2 % versus 78.7 % (P = 0.182) and 80.9 % versus 76.8 % (P = 0.444), respectively. Conversion to open surgery was associated with a non-significant reduction in OS and DFS. Stage-by-stage comparison showed no significant differences between the two groups. Both OS and DFS were similar between right colon and left-sided colon cancer patients. On multivariate analysis, pT4 cancer and a lymph node ratio of 0.20 or more were the only independent predictors of both OS and DFS.
The 10-year follow-up results confirm the oncological effectiveness of the laparoscopic approach to non-metastatic colon cancer.
结肠癌的腹腔镜切除术(LR)和开放切除术(OR)在5年随访时具有相似的肿瘤学结局。然而,随访时间更长的研究结果有限。本研究旨在比较LR和OR治疗非转移性结肠癌的10年肿瘤学结局。
在单一机构进行了一项前瞻性非随机试验,比较接受LR或OR治疗非转移性结肠癌的患者。基于“意向性治疗”原则并按实际治疗情况进行统计分析。比较Kaplan-Meier曲线以分析总生存期(OS)和无病生存期(DFS)。进行多变量分析以确定生存不良的预测因素。
该研究纳入了304例结肠癌患者:154例行LR,150例行OR。15例(9.7%)LR转为OR。在中位随访期138个月(范围120 - 220个月)内,LR和OR患者的10年OS率和DFS率无显著差异:分别为87.2%对78.7%(P = 0.182)和80.9%对